| |
|
|
|
Fennec Pharmaceuticals Inc.  
|
|
7.91 0.05 (0.01%) |
10-17 16:00 |
|
Open: |
7.79 |
Pre close: |
7.86 |
Target:
|
9.51
|
|
High: |
7.96 |
Low: |
7.71 |
Resistance:
|
8.14
8.74
|
|
Volume: |
19,069 |
Market Cap: |
150M |
Support:
|
7.17
5.97
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.80
 |
MACD |
MACD(12,26):
|
-0.26 |
|
MA(20): |
8.00  |
Signal(12,26,9): |
-0.29 |
|
MA(100): |
9.48 |
Stochastic Oscillator |
%K(14,3):
|
46.68 |
|
MA(250): |
9.96 |
%D(3): |
43.63 |
|
Average Volume(K) |
3-Month: |
8716
|
52-Week |
High:
|
14.99 |
|
10-Days: |
8282 |
Low: |
7.17 |
|
RSI |
RSI(14):
|
44.65 |
Change(%): |
-23.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.530 |
Return on Equity (ttm) |
-50.6 |
Shares Out. (M) |
18.79 |
|
EPS Est. Current Year |
-0.230 |
Return on Assets (ttm) |
-48.6 |
Shares Float (M) |
18.79 |
|
EPS Est. Next Year |
-0.210 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
71.50 |
|
Forward EPS |
-0.480 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
521 |
|
Book Value (p.s.) |
6.010 |
EBITDA (p.s.) |
-0.116 |
P/E |
-14.92 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.32 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-5.58 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-2.50 |
P/CF |
-26.64 |
|
|
|
|
|
|
